ISSN 2394-5125
 

Research Article 


THE EFFECT OF VISUAL ATTRACTIVENESS AND EEXPERIENCE ON THE E-LOYALTY (A STUDY OF ONLINE FASHION INDUSTRY AT JAKARTA)

Erlina Dwi Ratnasari, Mts Arief, Diena Dwidienawati.

Abstract
This aim of this study was to understand the influence of visual attractiveness and E-experience
to e-loyalty in shopping for fashion products online. This is a verification study and Structural Equation
Modeling (SEM) was used in determining the causality of visual attractiveness, e-experience, and e-loyalty. The
unit of analysis is online fashion shopping customers. A cross sectional observations were conducted
Observations are conducted. The population of this study is all internet users in Indonesia who have already
done shopping online for a fashion product. The minimum sample size of conducting a Structural Equation
Model (SEM) method was used in this study, with a total of 200 respondents. To get a sample of this
population, questionnaires were distributed to customers who were shopping for fashion in several shopping
centers in big cities. The results show that visual attractiveness has a greater influence than E-experience in
creating e-loyalty in shopping for fashion products online. The results have managerial contribution to online
fashion companies that to increase e-loyalty in shopping for fashion products that need to be pursued by
increasing visual attractiveness which is supported by the improvement in providing satisfying e-experience for
customers.

Key words: Visual Attractiveness, E-Experience, E-Loyalty.


 
ARTICLE TOOLS
Abstract
PDF Fulltext
How to cite this articleHow to cite this article
Citation Tools
Related Records
 Articles by Erlina Dwi Ratnasari
Articles by Mts Arief
Articles by Diena Dwidienawati
on Google
on Google Scholar


REFERENCES
1. American Psychiatric Association. Diagnostic and StatisticalManual of Mental Disorders, Fourth Edition. Washington, DC,American Psychiatric Association. 1994
2. Kessler RC, Sonnega A, Bromet E, Hughes M, Nelson CB.Posttraumatic stress disorder in the National Comorbidity Survey.Arch Gen Psychiatry 1995; 52(12):1048-60. [DOI via Crossref]    [Pubmed]   
3. Resnick HS, Kilpatrick DG, Dansky BS, Saunders BE, Best CL.Prevalence of civilian trauma and posttraumatic stress disorder ina representative national sample of women. J Consult Clin Psychol1993; 61(6):984-91. [DOI via Crossref]    [Pubmed]   
4. Kulka RA, Schlenger WE, Fairbank JA, Hough RL, Jordan BK,Weiss DS. Trauma and the Vietnam War generation: report offindings from the National Vietnam Veterans Readjustment Study.New York, Brunner/Mazel. 1990
5. Davidson J, Kudler H, Smith R, Mahorney SL, Lipper S, HammettE, et al. Treatment of posttraumatic stress disorder with amitriptylineand placebo. Arch Gen Psychiatry 1990; 47(3):259–66.
6. Frank JB, Kosten TR, Giller EL Jr, Dan E. A randomized clinicaltrial of phenelzine and imipramine for posttraumatic stress disorder.Am J Psychiatry 1988; 145(10):1289-91. [Pubmed]   
7. Kosten TR, Frank JB, Dan E, McDougole CJ, Giller EL.Pharmacotherapy for posttraumatic stress disorder using phenalzinean imipramine. J Nerv Ment Dis 1991; 179(6):366-70. [DOI via Crossref]    [Pubmed]   
8. Reist C, Kauffmann CD, Haier RJ, Sangdahl C, DeMet EM, Chicz-DeMet A, et al. A controlled trial of desipramine in 18 men withposttraumatic stress disorder. Am J Psychiatry 1989; 146(4):513-6. [Pubmed]   
9. Shestatzky M, Greenberg D, Lerer B. A controlled trial of phenelzinein posttraumatic stress disorder. Psychiatry Res 1988; 24(2):149-55. [DOI via Crossref]   
10. van der Kolk BA, Dreyfuss D, Michaels M, Shera D, Berkowitz R,Fisler R, et al. Fluoxetine in posttraumatic stress disorder. J ClinPsychiatry 1994; 55(12):517-22. [Pubmed]   
11. Hertzberg MA, Feldman ME, Beckham JC, Kudler HS, DavidsonJR. Lack of efficacy for fluoxetine in PTSD: a placebo controlledtrial in combat veterans. Ann Clin Psychiatry 2000; 12(2):101-5. [DOI via Crossref]    [Pubmed]   
12. Marmar CR, Schoenfeld F, Weiss DS, Metzler T, Zatzick D,Wu R, et al. Open trial of fluvoxamine treatment for combatrelatedposttraumatic stress disorder. J Clin Psychiatry Suppl 1996;57(8):66–70.
13. Kline NA, Dow BM, Brown SA, Matloff JL. Sertraline efficacy indepressed combat veterans with posttraumatic stress disorder. Am JPsychiatry 1994; 151(4):621. [Pubmed]   
14. Shay J. Fluoxetine reduces explosiveness and elevates mood ofVietnam combat veterans with PTSD. J Trauma Stress 1992;5(1):97–101.
15. First MB, Gibbon M, Spitzer RL, Williams JBW. StructuredClinical Interview for DSM-IV (SCID-1). Washington: AmericanPsychiatric Assosiation,1997
16. Çorapçýoðlu A, Aydemir Ö, Yýldýz M, Esen E, Köroðlu E. DSM IVEksen bozukluklarý (SCID-1) için yapýlandýrýlmýþ klinik görüþme,Klinik versiyon. Ankara: Hekimler Yayýn Birliði; 1999
17. Weathers FW, Keane TM, Davidson JRT. Clinician-AdministeredPTSD Scale: a review of the first ten years of research. DepressAnxiety 2001; 13(3):132-56. [DOI via Crossref]    [Pubmed]   
18. Guy W. ECDEU Assessment Manual for Psychopharmacology. USDept of Health Education, and Welfare publication (ADM) 76-338.Rockville, Md: National Institute of Mental Health;1976. P. 218-22.
19. Aker AT, Özeren M, Baþoðlu M, Kaptanoðlu C, Erol A, BuranB. Klinisyen tarafýndan uygulanan travma sonrasý stres bozukluðuölçeði (TSSB-Ö) geçerlik ve güvenilirlik çalýþmasý. Türk PsikiyatriDergisi - Turkish Journal of Psychiatry 1999; 10(4):286-93.
20. Beck AT, Steer RA. Manual for the Revised Beck DepressionInventory. San Antonio,Texas, Psychological Corp. 1987
21. Beck AT, Steer RA. Beck Anxiety Inventory Manual. San Antonio,Texas, Psychological Corp.1990
22. Stein DJ, Ipser J, McAnda N. Pharmacotherapy of PosttraumaticStress Disorder: A Review of Meta Analyses and TreatmentGuidelines. CNS Spectr 2009; 14:1(1):25-31.
23. Yorbýk Ö, Dikkatli S, Cansever A, Söhmen T. The efficacy offluoxetine treatment in children and adolescents with posttraumaticstress disorder symptoms. Klinik Psikofarmakoloji Bülteni - Bulletinof Clinical Psychopharmacology 2001; 11(4):251-6.
24. Zisook S, Chentsova-Dutton YE, Smith-Vaniz A, Kline NA,Ellenor GL, Kodsi AB, et al. Nefazodone in patients with treatmentrefractoryposttraumatic stress disorder. J Clin Psychiatry 2000;61(3):203-8. [DOI via Crossref]    [Pubmed]   
25. Hidalgo R, Hertzberg MA, Mellman T, Petty F, Tucker P, WeislerR, et al. Nefazodone in posttraumatic stress disorder: results fromsix open-label trials. Int Clin Psychopharmacol 1999; 14(2):61-8. [DOI via Crossref]    [Pubmed]   
26. Doruk A, Yetkin S, Aydýn H. The efficacy of sertraline on posttraumaticstress disorder. Klinik Psikofarmakoloji Bülteni - Bulletinof Clinical Psychopharmacology 1999; 9(1):47-52.
27. Peveler R, Kendrick T, Buxton M, Longworth L, Baldwin D,Moore M, et al. A randomised controlled trial to compare thecost-effectiveness of tricyclic antidepressants, selective serotoninreuptake inhibitors and lofepramine. Health Technol Assess 2005;9(16):1-134. [Pubmed]   
28. Van der Kolk BA, Spinazzola J, Blaustein ME, Hopper JW,Hopper EK, Korn DL, et al. A randomized clinical trial of eyemovement desensitization and reprocessing (EMDR), fluoxetine,and pill placebo in the treatment of posttraumatic stress disorder:treatment effects and long-term maintenance. J Clin Psychiatry2007; 68(1):37-46. [DOI via Crossref]    [Pubmed]   
29. Penava SJ, Otto MW, Pollack MH, Rosenbaum JF. Current statusof pharmacotherapy for PTSD: an effect size analysis of controlledstudies. Depress Anxiety 1996-1997; 4(5):240-2. [DOI via Crossref]   
30. Stein DJ, Ipser JC, Seedat S. Pharmacotherapy for posttraumatic stress disorder (PTSD). Cochrane Database Syst Re,2006;1:CD002795, [Pubmed]   
31. Zohar J, Amital D, Miodownik C, Kotler M, Bleich A, Lane RM,et al. Double-blind placebo-controlled pilot study of sertralinein military veterans with posttraumatic stress disorder. J ClinPsychopharmacol 2002; 22(2):190-5. [DOI via Crossref]   
32. Robert S, Hamner MB, Ulmer HG, Lorberbaum JP, Durkalski VL.Open-label trial of escitalopram in the treatment of posttraumaticstress disorder. J Clin Psychiatry 2006; 67(10):1522-6. [DOI via Crossref]    [Pubmed]   
33. Friedman MJ, Marmar CR, Baker DG, Sikes CR, Farfel GM.Randomized, double-blind comparison of sertraline and placebo forposttraumatic stress disorder in a Department of Veterans Affairssetting. J Clin Psychiatry 2007; 68(5):711-20. [DOI via Crossref]    [Pubmed]   
34. Kim Y, Asukai N, Konishi T, Kato H, Kato H, Hirotsune H, et al.Clinical evaluation of paroxetine in post-traumatic stress disorder(PTSD): 52-week, non-comparative open-label study for clinicaluse experience. Psychiatry Clin Neurosci 2008; 62(6):646-52. [DOI via Crossref]    [Pubmed]   
35. Marshall RD, Schneier FR, Fallon BA, Knight CB, Abbate LA,Goetz D, et al. An open trial of paroxetine in patients withnoncombat-related, chronic posttraumatic stress disorder. J ClinPsychopharmacol 1998; 18(1):10-8. [DOI via Crossref]   
36. Davidson JR, Kudler HS, Saunders WB, Erickson L, Smith RD,Stein RM, et al. Predicting response to amitriptyline in posttraumaticstress disorder. Am J Psychiatry 1993; 150(7):1024-9. [Pubmed]   
37. Ishii Y, Sumi T. Amitriptyline inhibits striatal efflux ofneurotransmitters via blockade of voltage-dependent Na1 channels.Eur J Pharmacol 1992; 221(2-3):377-80. [DOI via Crossref]   

How to Cite this Article
Pubmed Style

Erlina Dwi Ratnasari, Mts Arief, Diena Dwidienawati. THE EFFECT OF VISUAL ATTRACTIVENESS AND EEXPERIENCE ON THE E-LOYALTY (A STUDY OF ONLINE FASHION INDUSTRY AT JAKARTA). JCR. 2020; 7(16): 347-353. doi:10.31838/jcr.07.16.42


Web Style

Erlina Dwi Ratnasari, Mts Arief, Diena Dwidienawati. THE EFFECT OF VISUAL ATTRACTIVENESS AND EEXPERIENCE ON THE E-LOYALTY (A STUDY OF ONLINE FASHION INDUSTRY AT JAKARTA). http://www.jcreview.com/?mno=3501 [Access: June 01, 2021]. doi:10.31838/jcr.07.16.42


AMA (American Medical Association) Style

Erlina Dwi Ratnasari, Mts Arief, Diena Dwidienawati. THE EFFECT OF VISUAL ATTRACTIVENESS AND EEXPERIENCE ON THE E-LOYALTY (A STUDY OF ONLINE FASHION INDUSTRY AT JAKARTA). JCR. 2020; 7(16): 347-353. doi:10.31838/jcr.07.16.42



Vancouver/ICMJE Style

Erlina Dwi Ratnasari, Mts Arief, Diena Dwidienawati. THE EFFECT OF VISUAL ATTRACTIVENESS AND EEXPERIENCE ON THE E-LOYALTY (A STUDY OF ONLINE FASHION INDUSTRY AT JAKARTA). JCR. (2020), [cited June 01, 2021]; 7(16): 347-353. doi:10.31838/jcr.07.16.42



Harvard Style

Erlina Dwi Ratnasari, Mts Arief, Diena Dwidienawati (2020) THE EFFECT OF VISUAL ATTRACTIVENESS AND EEXPERIENCE ON THE E-LOYALTY (A STUDY OF ONLINE FASHION INDUSTRY AT JAKARTA). JCR, 7 (16), 347-353. doi:10.31838/jcr.07.16.42



Turabian Style

Erlina Dwi Ratnasari, Mts Arief, Diena Dwidienawati. 2020. THE EFFECT OF VISUAL ATTRACTIVENESS AND EEXPERIENCE ON THE E-LOYALTY (A STUDY OF ONLINE FASHION INDUSTRY AT JAKARTA). Journal of Critical Reviews, 7 (16), 347-353. doi:10.31838/jcr.07.16.42



Chicago Style

Erlina Dwi Ratnasari, Mts Arief, Diena Dwidienawati. "THE EFFECT OF VISUAL ATTRACTIVENESS AND EEXPERIENCE ON THE E-LOYALTY (A STUDY OF ONLINE FASHION INDUSTRY AT JAKARTA)." Journal of Critical Reviews 7 (2020), 347-353. doi:10.31838/jcr.07.16.42



MLA (The Modern Language Association) Style

Erlina Dwi Ratnasari, Mts Arief, Diena Dwidienawati. "THE EFFECT OF VISUAL ATTRACTIVENESS AND EEXPERIENCE ON THE E-LOYALTY (A STUDY OF ONLINE FASHION INDUSTRY AT JAKARTA)." Journal of Critical Reviews 7.16 (2020), 347-353. Print. doi:10.31838/jcr.07.16.42



APA (American Psychological Association) Style

Erlina Dwi Ratnasari, Mts Arief, Diena Dwidienawati (2020) THE EFFECT OF VISUAL ATTRACTIVENESS AND EEXPERIENCE ON THE E-LOYALTY (A STUDY OF ONLINE FASHION INDUSTRY AT JAKARTA). Journal of Critical Reviews, 7 (16), 347-353. doi:10.31838/jcr.07.16.42